TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive Michael Grever To Head DTP; Chabner’s Deputy Is Kaufman; Radiation Program To Be Split April 5, 1991
TCL Archive In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced August 3, 1990